QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases
-QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle ...
We haven't written up this one. Antara News Indonesia has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.